Descriptive, environmental and genetic epidemiology of nasopharyngeal carcinoma.I nNasopharyngeal carcinoma: Keys for Translational Medicine and Biology, Series Editor): Advances in Experimental Medicine and Biology], pp.23-41 ,
Epstein???Barr Virus MicroRNAs Are Evolutionarily Conserved and Differentially Expressed, PLoS Pathogens, vol.10, issue.3, p.23, 2006. ,
DOI : 10.1371/journal.ppat.0020023.sg006
Epstein-Barr Virus BART MicroRNAs Are Produced from a Large Intron prior to Splicing, Journal of Virology, vol.82, issue.18, pp.9094-9106, 2008. ,
DOI : 10.1128/JVI.00785-08
Comprehensive Profiling of Epstein-Barr Virus MicroRNAs in Nasopharyngeal Carcinoma, Journal of Virology, vol.83, issue.5, pp.2357-2367, 2009. ,
DOI : 10.1128/JVI.02104-08
Identification of Novel Epstein-Barr Virus MicroRNA Genes from Nasopharyngeal Carcinomas, Journal of Virology, vol.83, issue.7, pp.3333-3341, 2009. ,
DOI : 10.1128/JVI.01689-08
Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells, Virology Journal, vol.7, issue.1, p.271, 2010. ,
DOI : 10.1186/1743-422X-7-271
Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs, Cancer, vol.317, issue.pt 19, pp.698-710, 2012. ,
DOI : 10.1002/cncr.26309
Circulating microRNAs as stable blood-based markers for cancer detection, Proceedings of the National Academy of Sciences, vol.105, issue.30, pp.10513-10518, 2008. ,
DOI : 10.1073/pnas.0804549105
Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with Lp(a) Arteriosclerosis and thrombosis: a journal of vascular biology, pp.1066-1075, 1993. ,
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins, Nature Cell Biology, vol.257, issue.4, pp.423-433, 2011. ,
DOI : 10.1073/pnas.011404098
MicroRNAs in body fluids???the mix of hormones and biomarkers, Nature Reviews Clinical Oncology, vol.135, issue.8, pp.467-477, 2011. ,
DOI : 10.1038/nrclinonc.2011.76
Systemic mirnas as potential biomarkers for malignancy, International Journal of Cancer, vol.14, issue.Suppl 1, pp.2215-2222, 2012. ,
DOI : 10.1002/ijc.27642
Circulating microRNAs as noninvasive biomarkers in breast cancer. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer, pp.151-161, 2012. ,
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma, Proceedings of the National Academy of Sciences, vol.108, issue.12, pp.5003-5008, 2011. ,
DOI : 10.1073/pnas.1019055108
Characterization of extracellular circulating microRNA, Nucleic Acids Research, vol.39, issue.16, pp.7223-7233, 2011. ,
DOI : 10.1093/nar/gkr254
Epstein-Barr Virus and the Pathogenesis of Nasopharyngeal CarcinomasInNasopharyngeal Carcinoma: Keys for Translational Medicine and Biology, Series Editor): Advances in Experimental Medicine and Biology], pp.42-60 ,
The microRNAs of Epstein???Barr Virus are expressed at dramatically differing levels among cell lines, Virology, vol.386, issue.2, pp.387-397, 2009. ,
DOI : 10.1016/j.virol.2009.01.006
The Dynamics of EBV Shedding Implicate a Central Role for Epithelial Cells in Amplifying Viral Output, PLoS Pathogens, vol.82, issue.7, p.1000496, 2009. ,
DOI : 10.1371/journal.ppat.1000496.s008
Comparing the MicroRNA Spectrum between Serum and Plasma, PLoS ONE, vol.7, issue.7, p.41561, 2012. ,
DOI : 10.1371/journal.pone.0041561.s007
Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs, Cancer, vol.118, issue.18, pp.4634-4634, 2012. ,
DOI : 10.1002/cncr.26514
Human tumor virus utilizes exosomes for intercellular communication, Proceedings of the National Academy of Sciences, vol.107, issue.47, pp.20370-20375, 2010. ,
DOI : 10.1073/pnas.1014194107
Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases, Hepatology, vol.2, issue.5, pp.1946-57, 2012. ,
DOI : 10.1002/hep.25873
Overexpression of Epstein-Barr virus-encoded microRNA-BART7 in undifferentiated nasopharyngeal carcinoma, Anticancer Res, vol.32, pp.3201-3210, 2012. ,
Nasopharyngeal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up ,
Histopathological diagnosis of nasopharyngeal carcinoma -Looking beyond the blue bookInNasopharyngeal carcinoma: Keys for Translational Medicine and Biology, Series Editor): Advances in Experimental Medicine and Biology], pp.10-22 ,
Biological tools for NPC population screening and disease monitoring.I nNasopharyngeal Carcinoma: Keys for Translational Medicine and Biology, Series Editor): Advances in Experimental Medicine and Biology], pp.101-117 ,
The major CD9 and CD81 molecular partner. Identification and characterization of the complexes, J Biol Chem, vol.276, pp.14329-14337, 2001. ,
Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR, Journal of Medical Virology, vol.78, issue.3, pp.543-552, 2001. ,
DOI : 10.1002/jmv.2071
Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR), Methods, vol.50, issue.4, pp.298-301, 2010. ,
DOI : 10.1016/j.ymeth.2010.01.032
Consistent high concentration of the viral microRNA BART17 in plasma samples from nasopharyngeal carcinoma patients - evidence of non-exosomal transport, Virology Journal, vol.10, issue.1, p.119, 2013. ,
DOI : 10.1016/j.ymeth.2010.01.032
URL : https://hal.archives-ouvertes.fr/inserm-00835488